Pharmaceutical Enterprise (ME:200.708) » Johns Hopkins Drug Discovery
1715
page,page-id-1715,page-child,parent-pageid-25,page-template,page-template-full_width,page-template-full_width-php,ajax_fade,page_not_loaded,,qode-theme-ver-7.7,wpb-js-composer js-comp-ver-4.12.1,vc_responsive

Pharmaceutical Enterprise (ME:200.708)

Pipette

“Pharmaceutical Enterprise” is a discussion-driven and highly interactive course designed to provide students with greater insights into a range of topics related to the pharmaceutical enterprise. The course consists of seven modules, each of which begins with a pre-lecture discussion session proceeded by a lecture by an expert in the given subject, and post-lecture discussion session. This 3-segment format enables students to digest the topic thoroughly and gain in-depth knowledge through peer discussion and interaction with lecturers. The course is particularly suited for individuals interested to advance their career in the pharmaceutical sector.

Fall 2017
Course Director: Takashi Tsukamoto (ttsukamoto@jhmi.edu)
Location: Rangos Building Room 590
Time: 10:00 AM – 11:30 AM
Dates: Every Friday 9/1/2017-12/15/2017


Topic Activity
9/1 Introduction

Module 1: Intellectual Properties

Course opening remarks by Course Director

Pre-Lecture Discussion Session

9/8 Module 1: Intellectual Properties Lecture by Guido Galvez (Johns Hopkins Technology Ventures)
9/15 Module 1: Intellectual Properties

Module 2: Testing Drugs in Humans

Post-Lecture Discussion Session

Pre-Lecture Discussion Session

9/22 Module 2: Testing Drugs in Humans Lecture by Rosalie Filling/Carrie Lewis (Lupin Pharmaceuticals)
9/29 Module 2: Testing Drugs in Humans

Module 3: Drug Manufacturing

Post-Lecture Discussion Session

Pre-Lecture Discussion Session

10/6 Module 3: Drug Manufacturing Lecture by Mark Schenerman (MedImmune)
10/13 Module 3: Drug Manufacturing

Module 4: Clinical Development Success Rates

Post-Lecture Discussion Session

Pre-Lecture Discussion Session

10/20 Module 4: Clinical Development Success Rates  Lecture by David Thomas (Biotechnology Innovation Organization)
10/27 Module 4: Clinical Development Success Rates

Module 5: The Story of Cardioxyl

Post-Lecture Discussion Session

Pre-Lecture Discussion Session

11/3 Module 5: The Story of Cardioxyl  Lecture by John Toscano (Johns Hopkins University)
11/10 Module 5: The Story of Cardioxyl

Module 6: Venture Philanthropy

Post-Lecture Discussion Session

Pre-Lecture Discussion Session

11/17  Module 6: Venture Philanthropy Lecture by Robert J. Beall (Formerly with Cystic Fibrosis Foundation)
12/1 Module 6: Venture Philanthropy

Module 7: Drug Pricing

Post-Lecture Discussion Session

Pre-Lecture Discussion Session

12/8 Module 7: Drug Pricing Lecture by Gerard Anderson (Bloomberg School of Public Health)
12/15 Module 7: Drug Pricing Post-Lecture Discussion Session

Grades will be determined by class participation (50%) and one lecture report assignment (50%). No prior knowledge in drug discovery is required. This course is recommended for students in the 2nd or subsequent years of their graduate program, postdoctoral fellows, and faculty members. Blackboard will be used to communicate with students, share course materials, make announcements, submit assignments, and post grades.

Please contact Dr. Takashi Tsukamoto (ttsukamoto@jhmi.edu) for more information.

Important information for students with disabilities: All students with disabilities who require accommodations for this course should contact Catherine L. Will, Disability Services Coordinator for Graduate Biomedical Education (cwill@jhmi.edu or 410-614-3781) at their earliest convenience to discuss their specific needs. Please note that accommodations are not retroactive.

lowgo_bottom